Roivant Sciences Ltd., 10% Owner at Urovant Sciences Ltd. (UROV), bought 44,022 shares at $7.95 ($355K) on 2019-06-13, disclosed to the SEC on 2019-06-14.
Scheduled purchase ($355k) by 10% Owner under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $8.30 | 7,500 | $62K | 17.6% |
| 2 | $8.30 | 7,500 | $62K | 17.6% |
| 3 | $7.95 | 7,367 | $59K | 16.5% |
| 4 | $7.95 | 7,367 | $59K | 16.5% |
| 5 | $7.91 | 7,144 | $57K | 15.9% |
| 6 | $7.91 | 7,144 |
| $57K |
| 15.9% |
| Total | $8.06 avg | 44,022 | $355K | 100% |
| Filing → |
| IMVT | BUY | 2023-10-04 | $58.0M | — | Filing → |
| IMVT | BUY | 2022-10-07 | $2.5M | — | Filing → |
| IMVT | BUY | 2020-09-04 | $12.5M | — | Filing → |